ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“ESMO is pleased to announce the publication of a joint paper with SIOG – International Society of Geriatric Oncology including pragmatic strategies to improve the representation of older patients in clinical trials.
The paper underscores key considerations related to the urgent need to better serve this patient population in order to improve their outcomes:
- Inclusion of older adults in Clinical Trials ensures that research findings are relevant and applicable in this population.
- Engaging patients and caregivers in trial design ensures outcomes that reflect the priorities and needs of older adults.
- Adaptive and pragmatic trial designs improve inclusion and participation of older adults in Cancer Research.
- Trial designs should include geriatric assessment and management to inform treatment decisions in clinical trials.
- Consider various strategies to implement trial endpoints and designs that are meaningful to older adults.”
Title: The ESMO/SIOG Cancer in the Elderly Working Group pragmatic strategies for clinical trial designs and endpoints in older adults with cancer.
Authors: C. Baldini, A.R.A. Mislang, K.-L. Cheung, S. Pilleron, H. Wildiers, S. Rostoft, N.R. Neuendorff, M. Frelaut, R. Kanesvaran, D. Papamichael, S. O’Hanlon, M. Puts, F. Canoui-Poitrine, L. Dal Lago, W.K. Soo, A. O’Donovan, F. Gomes, L. Cooper, B. Canin, M. Bringuier, N.M.L. Battisti, L. Biganzoli, E. Brain.
